Exact Sciences Corporation has announced an expanded partnership with Humana Inc. to improve access to colorectal cancer screening through the Cologuard Plus™ test. Starting in August 2025, this test will be available as an in-network service for Humana's Medicare Advantage members nationwide. With approximately 5.8 million members, Humana is the fourth largest private insurer in the U.S. Cologuard Plus, launched in March 2025, is FDA-approved, covered by Medicare, and included in the U.S. Preventive Services Task Force guidelines. This collaboration aims to make colorectal cancer screening more accessible, supporting early detection and effective treatment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.